We continue to pursue efforts to create a more equitable flying experience by listening and learning directly from people living with rare, neuromuscular diseases. Ashley shares one of her biggest challenges of living with Spinal Muscular Atrophy (SMA): navigating accessible travel. Read her perspective on what it’s like traveling with SMA: https://ow.ly/yaF950V3JVX #RareDiseaseDay | #SpinalMuscularAtrophy
About us
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries. For more information, please visit www.biogen.com. Community Guidelines: https://www.biogen.com/community-guidelines.html Follow us on social media – LinkedIn, Facebook, X, and YouTube.
- Website
-
http://www.biogen.com
External link for Biogen
- Industry
- Biotechnology Research
- Company size
- 5,001-10,000 employees
- Headquarters
- Cambridge, MA
- Type
- Public Company
Locations
-
Primary
225 Binney Street
Cambridge, MA 02142, US
-
Landis & Gyr-Strasse 3
Zug, CH 6300, CH
-
P.O. Box 14627
5000 Davis Drive
Research Triangle Park, NC 27709, US
Employees at Biogen
-
Bjoern Rosner
Executive Leader | Digital Operations | Biotech | Pharma | Driving product commercialization and digital innovation from conception to deployment…
-
Saleem Hussaini
Business Technology Leader | Life Sciences | @Biogen
-
Frode Hellesnes
-
Stavros Platakis
Global Head Customer Excellence and Operations BBU at Biogen
Updates
-
We are excited to announce a new collaboration with Stoke Therapeutics for a potential first-in-class disease modifying medicine in development for the treatment of Dravet syndrome. Read the news: https://bit.ly/430ub1b #News
-
Apply for our Worldwide Medical Ph.D. Fellowship today! This opportunity provides recent doctoral graduates with a hands-on introduction to the biotech industry and a career in medical affairs. Submit your resume and cover letter by March 31st: https://ow.ly/khi150UZnIs
-
This morning, we reported our Q4 and full year 2024 financial results. Watch the full recording here: https://ow.ly/ol9R50UYCxf #Earnings | $BIIB | #FinancialResults
-
Friedreich ataxia (FA) is a rare, genetic and debilitating neurodegenerative disease that affects around 15,000 individuals globally. Hear Carla, Maria, and Nuria share their perspectives. Learn more about FA: https://ow.ly/SAZ950UXa3a #RareDiseaseDay | #FriedreichAtaxia
-
STARTING SOON: Join our Q4 and full year 2024 financial results live webcast at 8:30 AM ET. Join here: https://ow.ly/v5vV50UY8Lb #Earnings | $BIIB | #FinancialResults
-
In recognition of International Day of Women and Girls in Science, we’re emphasizing our commitment to encouraging and providing young women with the resources to explore a career in STEM. Science, technology, engineering, and math help drive breakthroughs that shape the future of healthcare, and that future is brightest when it reflects people of all backgrounds, perspectives and ideas. Learn more about our innovative work: https://lnkd.in/ex3NtHDK #WomenInScience | #WomenInSTEM
-
While some people may think mentoring only goes one way, our Pharmaceutical Operations and Technology team puts a different spin on mentoring. Through our Reverse Mentoring Program, we empower employees to become mentors to more senior leaders to cultivate an inclusive environment, strengthen working relationships, and gain a new perspective. Hear first-hand from our colleagues about their experiences with the program: https://ow.ly/kgsi50UUcKs #TeamBiogen
-
-
We continue to push the boundaries of Alzheimer’s disease research, building on the understanding of the roles of amyloid plaques and neurofibrillary tangles. Our Scientific Director and the Interim Head of the Neurodegeneration Research Unit, Heike Hering, along with our Alzheimer’s disease research and development team, are leading the way in developing treatments that could make a real difference for people living with Alzheimer’s disease. Learn more about our ongoing research here: https://ow.ly/cON150UQlNs #AlzheimersDisease
-
🎥 Neues Jahr, neues Format: #FokusBiotech! 🔍 Warum sterben Nervenzellen ab? Was geschieht bei Krankheiten wie ALS oder SMA? Diese spannenden Fragen nehmen wir in unserem neuen Wissenschaftsformat #FokusBiotech unter die Lupe! 🔬 Hier tauchen wir tief in biotechnologische und medizinische Themen ein, erklären aktuelle Fortschritte und machen komplexe Zusammenhänge greifbar. In unserer ersten Folge dreht sich alles um die Geheimnisse unserer Nervenzellen und was passiert, wenn sie nicht richtig arbeiten. 🧬Schauen Sie vorbei und entdecken Sie die Welt der Wissenschaft mit uns! #WissenschaftErklärt #MedizinischeFortschritte #Biotechnologie #Wissenschaft
Affiliated pages
Similar pages
Browse jobs
Stock
BIIB
NASDAQ
20 minutes delay
$141.27
0.63 (0.448%)
- Open
- 141.275
- Low
- 139.35
- High
- 144.17
Data from Refinitiv
See more info on